State of the Art Brain Tumor Diagnostics, Imaginig, and Therapeutics, An Issue of Neuroimaging Clinics
Meng Law, MD
This Neuroimaging publication presents information in three distinct sections: Diagnostics, Planning/Imaging, and Therapeutics. Topics include State of the Art Pathology (New tools, New WHO classification/implications); Applications of nanotechnology in the imaging and therapy of brain tumors; Molecular Tools (Biology, Prognosis and Therapeutic Triage in Gliomas); Surgical planning and intra-operative MR in brain tumor surgery; Imaging of brain tumors via DTI and fMRI; Imaging of brain tumors via MR Spectroscopy and Metabolic Imaging; Imaging of brain tumors: Perfusion Permeability; Novel Gadolinium liposomal contrast agents; Current status and future potential of MRI-guided focused ultrasound surgery; Update on surgically based clinical trials in brain tumors including new neurosurgical techniques; Novel medical therapeutics in brain tumors, including targeted molecular therapies, current and future clinical trials; and Radiation oncology in brain tumors, current approaches and clinical trials in progress.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.